Regan Andrew — SEC Form 4 filings
SEC reporting owner CIK 1991325. 6 Form 4 filings on record with FilingPulse; latest filed 2026-09-02.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-09-19 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 11 legs across 2 filings — 15,301,358 shares, $4,592,487 total (shares × price as filed on priced legs).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 10,244,392 shares @ $0.32 ($3,246,448) in CDT Equity Inc., filed 2024-09-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CDT Equity Inc. (CDT) | Chief Executive Officer, Director | 6 | — | 11 legs · 15,301,358 sh · $4,592,487 | 12 |
Form 4 filings — Regan Andrew
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-02 | 4 | CDT Equity Inc. (CDT) | Other (J): 5,436,830 · Sale (S): 290 · Other (J): 5,436,830 (derivative) @ $0.00 · Option exercise/expiry (X): 5,436,830 (derivative) @ $0.00 | EDGAR |
| 2026-05-14 | 4 | CDT Equity Inc. (CDT) | Grant/award (A): 147,401 · Grant/award (A): 100,000 @ $1.90 · Conversion (C): 147,401 (derivative) @ $0.00 | EDGAR |
| 2025-12-22 | 4 | CDT Equity Inc. (CDT) jointly with Corvus Capital Ltd. | Grant/award (A): 224,800 @ $1.79 · Grant/award (A): 3,685,815 (derivative) @ $0.00 | EDGAR |
| 2025-09-22 | 4 | CDT Equity Inc. (CDT) | Grant/award (A): 1,120,000 @ $0.69 | EDGAR |
| 2025-06-13 | 4 | CONDUIT PHARMACEUTICALS INC. (CDT) jointly with Corvus Capital Ltd. | Grant/award (A): 154,799 @ $3.23 | EDGAR |
| 2024-09-19 | 4 | CONDUIT PHARMACEUTICALS INC. (CDT) jointly with Corvus Capital Ltd., Algo Holdings, Inc. | Other (J): 1,100,000 · Other (J): 1,100,000 · Sale (S): 1,000 @ $0.64 · Sale (S): 35,923 @ $0.51 · Sale (S): 77,681 @ $0.44 · Sale (S): 150,000 @ $0.33 · +6 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1991325 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →